Xenon Pharmaceuticals/$XENE
About Xenon Pharmaceuticals
Ticker
Industry
Headquarters
Employees
XENE Metrics
$2.9B
-
-$2.82
1.25
-
Price and volume
Market cap
$2.9B
Beta
1.25
52-week high
$50.99
52-week low
$35.53
Average daily volume
376K
Financial strength
Current ratio
22.214
Quick ratio
22.024
Long term debt to equity
1.053
Total debt to equity
1.227
Management effectiveness
Return on assets (TTM)
-21.19%
Return on equity (TTM)
-29.75%
Valuation
Price to book
3.63
Price to tangible book (TTM)
3.63
Price to free cash flow (TTM)
-18.234
Growth
Earnings per share change (TTM)
5.34%
3-year earnings per share growth (CAGR)
22.09%
What the Analysts think about XENE
Analyst Ratings
XENE Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
XENE Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
XENE News
FAQs
What’s the current market cap for Xenon Pharmaceuticals stock?
What is the P/E ratio for Xenon Pharmaceuticals stock?
Does Xenon Pharmaceuticals stock pay dividends?
No, Xenon Pharmaceuticals (XENE) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Xenon Pharmaceuticals dividend payment date?
Xenon Pharmaceuticals (XENE) stock does not pay dividends to its shareholders.
What is the beta indicator for Xenon Pharmaceuticals?
Xenon Pharmaceuticals (XENE) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.